Immutep Reports Positive Results in First Line Head and
Media Release Efti in combination with KEYTRUDA® (pembrolizumab) achieved a 35.5% response rate in evaluable patients (N=31), according to RECIST ...
Read more
ADVERTISEMENT
ADVERTISEMENT
Tag: Immutep
Immutep Announces Details for Oral Presentation at ESMO
Company to Host Webcast on 12th July at 9am AEST (7pm ET, 11 July) SYDNEY, AUSTRALIA, July 03, 2024 (GLOBE ...
Read moreImmutep successfully completes institutional placement and
Sydney, Australia, June 05, 2024 (GLOBE NEWSWIRE) -- Immutep Limited ACN 009 237 889 (ASX: IMM, NASDAQ: IMMP) (Immutep or ...
Read moreImmutep Announces Clinical Collaboration with MSD to
Phase III collaboration will evaluate efti in combination with KEYTRUDA, MSD’s anti-PD-1 therapy, and standard chemotherapy in first-line non-small cell ...
Read moreImmutep Announces New Biomarker Data from TACTI-002 Phase
Media Release Statistically significant increases of Th1 biomarkers (IFN-gamma, CXCL-10), circulating immune cells (lymphocytes), and RNA levels of immune ...
Read more
LifeCare News is a registered magazine in RNI (Registrar of Newspapers for India) is started in 2015, as well as Lifecarenews have a malti language portal. Life Care News portal was connected with many reputed news agency.